Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trialFrançois Quénet, Patrick Rat, Dominique Élias et al.|The Lancet Oncology|2021Cited by 812
Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trialJean-Marc Classe, Olivier Gléhen, Fabrice Lécuru et al.|The Lancet Oncology|2024Cited by 70
Quelle prise en charge optimale pour un sarcome du cordon spermatique en 2018 ?Sébastien Carrère, Sylvie Bonvalot, R. Tétreau et al.|The French Journal of Urology|2018Cited by 3
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer (CHIPOR): A Randomized, Open-Label, Phase 3 TrialJean-Marc Classe, Olivier Gléhen, Pierre Méeus et al.|Obstetrical & Gynecological Survey|2025Cited by 0